Literature DB >> 10546748

Post-hysterectomy fallopian tube carcinoma presenting with a positive Papanicolaou smear.

D P Warshal1, E R Burgelson, J K Aikins, T F Rocereto.   

Abstract

BACKGROUND: Fallopian tube carcinoma is a rare gynecologic malignancy. The majority of women present with vaginal bleeding and have advanced disease. CASE: A 76-year-old woman presented 34 years after vaginal hysterectomy with a routine Papanicolaou smear showing adenocarcinoma. Rectovaginal examination was remarkable for thickening at the vaginal apex. Colposcopy found a pinpoint opening in this area, and a cytobrush passed through the opening confirmed adenocarcinoma. Pelvic ultrasound, computed tomography scan, and CA 125 were normal. At laparotomy, the right fallopian tube and ovary were adherent to the vaginal apex. A grade II papillary serous adenocarcinoma confined to the tube was discovered.
CONCLUSION: According to a MEDLINE search, this is the third report detailing a unique presentation of fallopian tube carcinoma after hysterectomy and possibly the first detected with positive Papanicolaou cytology.

Entities:  

Mesh:

Year:  1999        PMID: 10546748     DOI: 10.1016/s0029-7844(99)00241-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Primary fallopian tubal transitional cell carcinoma with exfoliation of malignant cells in cervical Pap smear.

Authors:  Nalini Gupta; Radhika Srinivasan; Raje Nijhawan; Lakhbir Kaur Dhaliwal
Journal:  Cytojournal       Date:  2005-12-09       Impact factor: 2.091

Review 2.  Fallopian tube prolapse after hysterectomy: a systematic review.

Authors:  Lobna Ouldamer; Agnès Caille; Gilles Body
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

Review 3.  Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding.

Authors:  Isao Otsuka; Takuto Matsuura
Journal:  Diagnostics (Basel)       Date:  2020-02-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.